Ovid Therapeutics Inc (OVID)
3.06
+0.07
(+2.34%)
USD |
NASDAQ |
Apr 26, 15:00
Ovid Therapeutics Price to Book Value: 2.464 for April 26, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 2.408 |
| April 24, 2024 | 2.537 |
| April 23, 2024 | 2.577 |
| April 22, 2024 | 2.537 |
| April 19, 2024 | 2.601 |
| April 18, 2024 | 2.585 |
| April 17, 2024 | 2.505 |
| April 16, 2024 | 2.553 |
| April 15, 2024 | 2.577 |
| April 12, 2024 | 2.577 |
| April 11, 2024 | 2.634 |
| April 10, 2024 | 2.561 |
| April 09, 2024 | 2.609 |
| April 08, 2024 | 2.593 |
| April 05, 2024 | 2.618 |
| April 04, 2024 | 2.456 |
| April 03, 2024 | 2.456 |
| April 02, 2024 | 2.456 |
| April 01, 2024 | 2.489 |
| March 28, 2024 | 2.456 |
| March 27, 2024 | 2.456 |
| March 26, 2024 | 2.416 |
| March 25, 2024 | 2.489 |
| March 22, 2024 | 2.577 |
| March 21, 2024 | 2.456 |
| Date | Value |
|---|---|
| March 20, 2024 | 2.247 |
| March 19, 2024 | 2.215 |
| March 18, 2024 | 2.199 |
| March 15, 2024 | 2.191 |
| March 14, 2024 | 2.215 |
| March 13, 2024 | 2.271 |
| March 12, 2024 | 2.279 |
| March 11, 2024 | 2.368 |
| March 08, 2024 | 2.481 |
| March 07, 2024 | 2.553 |
| March 06, 2024 | 2.618 |
| March 05, 2024 | 2.634 |
| March 04, 2024 | 2.689 |
| March 01, 2024 | 2.738 |
| February 29, 2024 | 2.738 |
| February 28, 2024 | 2.762 |
| February 27, 2024 | 2.923 |
| February 26, 2024 | 2.963 |
| February 23, 2024 | 2.979 |
| February 22, 2024 | 2.963 |
| February 21, 2024 | 2.874 |
| February 20, 2024 | 2.995 |
| February 16, 2024 | 3.092 |
| February 15, 2024 | 2.931 |
| February 14, 2024 | 3.036 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.7143
Minimum
Nov 07 2022
15.43
Maximum
Aug 19 2020
2.855
Average
2.025
Median
Price to Book Value Benchmarks
| Ligand Pharmaceuticals Inc | 1.799 |
| NovaBay Pharmaceuticals Inc | 1.812 |
| Palatin Technologies Inc | -- |
| iBio Inc | 0.6592 |
| Theriva Biologics Inc | 0.1946 |
Price to Book Value Related Metrics
| PS Ratio | 551.41 |
| Price | 3.06 |
| Earnings Yield | -24.51% |
| Market Cap | 216.37M |